Centre Hospitalier Regional Et Universitaire De Brest — Sponsor Intelligence | 18 EU Trials

Filter these 18 trials by condition, phase, country and more.

Open in Search →

18 Registered trials

5 Recruiting

6 Completed trials

2 Countries active

26 Unique IMPs

100% Results reported

Phase III

Phase II

Phase III: 12 Phase II/III: 1 Phase II: 4 Phase I/II: 1

Oversight events:

2 corrective measures across 2 trials

View oversight register →

100%

6 of 6 completed trials have published summary results (EU CTR Article 37 — 12-month obligation).

View full Transparency Scoreboard →

Top indications

Aortic stenosis 1 Post procedural pulmonary embolism 1 Venous thrombosis 1 Polymyalgia rheumatica 1 Deep vein thrombosis postoperative 1 Pulmonary venous thrombosis 1 Deep vein thrombosis 1 Pulmonary embolism 1

Top IMPs

GALLIUM (68GA), HUMAN ALBUMIN AS MACROAGGREGATES 2 (S)-2,2',2''-(10-(2-(4-(3-((4-(2-(2-CYANO-4,4-DIFLUOROPYRROLIDIN-1-YL)-2-OXOETHYLCARBAMOYL)-QUINOLIN-6-YL)(METHYL)AMINO)-PROPYL)PIPERAZIN-1-YL)-2-OXOETHYL)-68GA-[1,4,7,10]-TETRAAZACYCLODODECANE-1,4,7-TRIYL)TRIACETATE 1 2-[[5-[3-[[6-[[(5S)-5-CARBOXY-5-[[(1S)-1,3-DICARBOXYPROPYL]CARBAMOYLAMINO]PENTYL]AMINO]-6-OXOHEXYL]AMINO]-3-OXOPROPYL]-2-OXIDOPHENYL]METHYL-[2-[[5-(2-CARBOXYETHYL)-2-OXIDOPHENYL]METHYL-(CARBOXYLATOMETHYL)AMINO]ETHYL]AMINO]ACETATE:GALLIUM-68(3+) HYDRON 1 ACETYLSALICYLIC ACID 1 ANAKINRA 1 APIXABAN 1 BARICITINIB 1 BOTULINUM TOXIN TYPE A 1 CAPSAICIN 1 FLUDEOXYGLUCOSE (18F) 1 GALLIUM (68GA) CHLORIDE 1 GOZETOTIDE 1

All trials

18 total

Apixaban/rivaroxaban Versus Aspirin for primary prevention of thrombo-embolic complications in JAK2V617F-positive myeloproliferative neoplas… Pending

2024-515362-13-00 Phase II/III 1 country ACETYLSALICYLIC ACID; APIXABAN; RIVAROXABAN
Contribution of ICG Angiography in the Detection of Parathyroids and the Prevention of Hypoparathyroidism Post Total Thyroidectomy Pending

2024-516255-41-00 Phase III 1 country INDOCYANINE GREEN
Ventilation/Perfusion PET/CT with Galligas and 68Ga-MAA for regional lung function assessment after pulmonary embolism Pending

2024-518293-13-01 Phase I/II 1 country GRAPHITE; HUMAN ALBUMIN AS MACROAGGREGATES
Pegasus 2 Pending

2024-519465-22-01 Phase III 1 country GALLIUM (68GA), HUMAN ALBUMIN AS MACROAGGREGATES
Efficacy and safety of early intramuscular botulinum toxin injections in the prevention of shoulder deformity in infants with obstetric brac… Pending

2024-520391-10-01 Phase III 1 country BOTULINUM TOXIN TYPE A
SOFAPI Pending

2025-520731-17-02 Phase III 1 country (S)-2,2',2''-(10-(2-(4-(3-((4-(2-(2-CYANO-4,4-DIFLUOROPYRROLIDIN-1-YL)-2-OXOETHY…
Interleukin-1 inhibition to improve the response of myeloproliferative neoplasms resistant to cytoreductive treatment Pending

2025-523921-17-00 Phase II 1 country ANAKINRA
Justification AnD evaluation, in pOlymyalgia RhEumatica, of BARIcitinib versus placebo (JADORE-BARI study) Recruiting

2024-518385-26-01 Phase III 1 country BARICITINIB
The NIPA study: A randomized double-blind control clinical trial Naloxegol administration to prevent opioids induced gastrointestinal motili… Recruiting

2024-512004-19-01 Phase III 1 country NALOXEGOL OXALATE
Impact of local tissue inflammation on intramyocardial conduction pathways post percutaneous valve : evaluation by positron emission tomogra… Recruiting

2024-514587-44-00 Phase II 1 country FLUDEOXYGLUCOSE (18F)
StAtins for Venous Event Reduction in Patients with Venous Thromboembolism : The SAVER Trial Recruiting

2023-504486-23-00 Phase III 2 countries
CAPSAPED Recruiting

2022-500265-27-00 Phase III 1 country CAPSAICIN; TRAMADOL
Comparison of an inhaled sedation strategy with an intravenous sedation strategy in intensive care patients treated with invasive mechanical… Ended

2024-513530-37-00 Phase III 1 country ISOFLURANE; PROPOFOL
Screening for occult malignancy using 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography (FDG PET/CT) in patients with … Ended

2024-514703-34-00 Phase III 1 country GALLIUM (68GA) CHLORIDE
Lung Microbiota’s evolution after use of Nitrous Oxide on pediatric patient needing airway samples - MicroNO Ended

2024-518197-14-00 Phase II 1 country NITROUS OXIDE, OXYGEN
A randomized, open-label, controlled phase III trial comparing the pembrolizumab platinum based chemotherapy combination with pembrolizumab … Ended

2024-513697-22-00 Phase III 1 country
Prospective double-blind randomized comparative study of the use of methoxyflurane vs placebo in the management of pain in oral and dental e… Ended

2023-508216-29-00 Phase III 1 country METHOXYFLURANE
Diagnostic Performance of Prostate Specific Membrane Antigen (PSMA) Positron Emission Tomography/Computed Tomography (PET/CT) Imaging for Pr… Ended

2024-516319-25-00 Phase II 1 country 2-[[5-[3-[[6-[[(5S)-5-CARBOXY-5-[[(1S)-1,3-DICARBOXYPROPYL]CARBAMOYLAMINO]PENTYL…

Showing 1–18 of 18 trials

← All sponsors A–Z